Member Info for BOJO2020

It’s a good post alright (11.23) but by crikey BBN you need to pay attention to word economy…Two double posts in a row. Imagine if you could sum up your points in a sentence or two, you would still get your point across and the rest of us would have several minutes of us lives back.

Anyway, thanks. I think…

Stupid question perhaps but does it cost anything for Scancell to present at these conferences?

EE,

Well I don't get replies to my emails from Scancell (I have tried several times). I have no problems in communications with other companies I am invested in. They should respond to all emails.

Hi Burble,

Appreciate you taking the time to share your thoughts which have helped me focus on relevant points. So early data shows Moditope has demonstrated potential in humans. Not getting carried away but this is encouraging.

EC,

You forgot TGTD. They are at least 24 hours behind everyone else!

Don’t think it is Scancell

72% up on the month that basically wipes out his 80% down argument

So you will not find trial protocol etc

It’s a private study that involves Parsortix NHS in four cancer indications. 1000 subjects

TGTD,

You are a silly billy!

Wonder if AZ have registered labs in which they can validate what the hell they wish in the blink of an eye!

You just sit quietly in the corner. Everything will be alright :-)

Yes it spiked at 37p for a few hours and held 31p for a good while in Jan

They are discussing the MRNA skin cancer vax btw

Good listen. I have whattsapped them about SCIB1. Expect to be ignored!

Thanks C11,

Just to add that both may prove to have further utility and each will plough it's own furrow so to speak. It is important to remember the development opportunities that may arise from these types of platform. There-in lays the real value me thinks. But first lets get iSCIB1+ validated!

Another will probably be along shortly…

Looks like Vulpes were holding shares in Chronus as a private company which have now translated to an Evgen holding. There may or may not have been some additional buying.

Yes and Scancell

Agree Rick and thanks Bermuda for the link. Not seeing any real gains today is very odd but the market is clapped out so I guess brilliant news is just wasted on AIM? I am watching out for another hot RNS that might kick start a rise before results.

Parsortix still works. It always did...

Huge pat on the back to the scientists at Angle

Hi Desouzaa,

Might you be thinking of the double checkpoint achieving 53% ORR?